文献速递白内障与屈光手术角膜与眼表疾病

兔眼晶状体中Myo/Nog细胞清除减轻后囊膜混浊

Depletion of Myo/Nog Cells in the Lens Mitigates Posterior Capsule Opacification in Rabbits.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2019-01-01

该研究在兔白内障手术中注射G8抗体偶联3DNA纳米载体携带多柔比星(G8:3DNA:Dox)清除晶状体Myo/Nog细胞。结果显示含9至36 μM多柔比星的G8:3DNA处理眼均未出现超过微量水平的中部后囊膜混浊,不足9%的眼出现超过轻度水平的周边后囊膜混浊。作者结论认为Myo/Nog细胞是术后晶状体肌成纤维细胞的主要来源,靶向清除有预防后囊膜混浊的潜力。

要点

  • G8:3DNA:Dox特异性诱导晶状体Myo/Nog细胞死亡。
  • 含9至36 μM多柔比星的G8:3DNA处理眼均未超过微量水平中部后囊膜混浊。
  • 不足9%的处理眼出现超过轻度水平的周边后囊膜混浊。

核心结论

  • Myo/Nog细胞是白内障术后晶状体肌成纤维细胞的主要来源。
  • 靶向清除Myo/Nog细胞有预防后囊膜混浊和保留视力的潜力。

研究设计与样本

  • 在兔白内障手术中注射G8抗体偶联3DNA纳米载体携带多柔比星(G8:3DNA:Dox)以清除Myo/Nog细胞。
  • 通过裂隙灯分析、大体与组织学观察及α-平滑肌肌动蛋白免疫荧光定位对后囊膜混浊严重程度进行评分。

主要发现

  • G8:3DNA:Dox特异性诱导晶状体Myo/Nog细胞死亡。
  • 含9至36 μM多柔比星的G8:3DNA处理眼均未出现超过微量水平的中部后囊膜混浊,囊膜上肌成纤维细胞很少。
  • 不足9%的含9至36 μM多柔比星的G8:3DNA处理眼出现超过轻度水平的周边后囊膜混浊。
  • 多柔比星本身可减轻后囊膜混浊,但晶状体中肌成纤维细胞和皱褶丰富,且在睫状突和角膜观察到脱靶效应。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Posterior capsule opacification (PCO) is a vision-impairing disease that occurs in some adults and most children after cataract surgery. Contractile myofibroblasts contribute to PCO by producing wrinkles in the lens capsule that scatter light. Myofibroblasts in the lens originate from Myo/Nog cells named for their expression of the MyoD transcription factor and bone morphogenetic protein inhibitor noggin. In this study we tested the effects of depleting Myo/Nog cells on development of PCO. METHODS: Myo/Nog cells were eliminated by injecting the G8 antibody conjugated to 3DNA nanocarriers for the cytotoxin doxorubicin (G8:3DNA:Dox) during cataract surgery in rabbits. The severity of PCO was scored by slit lamp analysis, gross and histologic observation, and immunofluorescence localization of α-smooth muscle actin. RESULTS: G8:3DNA:Dox specifically induced cell death in Myo/Nog cells in the lens. None of the lenses administered G8:3DNA containing 9 to 36 μM doxorubicin developed greater than trace levels of central PCO and few myofibroblasts were present on the capsule. Less than 9% of these lenses exhibited greater than mild levels of peripheral PCO. Doxorubucin itself reduced PCO; however, myofibroblasts and wrinkles were abundant in the lens, and off-target effects were observed in the ciliary processes and cornea. CONCLUSIONS: Myo/Nog cells are the primary source of myofibroblasts in the lens after cataract surgery. Targeted depletion of Myo/Nog cells has potential for preventing PCO and preserving vision.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Gerhart J, Werner L, Mamalis N, et al. Depletion of Myo/Nog Cells in the Lens Mitigates Posterior Capsule Opacification in Rabbits. Invest Ophthalmol Vis Sci. 2019. PMID: 31042787. doi:10.1167/iovs.19-26713

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。